ANG-2 inhibition to treat multiple sclerosis

Details for Australian Patent Application No. 2012216488 (hide)

Owner Amgen Inc.

Inventors Kirchner, Jacqueline A.; Mustelin, Tomas Mikael

Agent Shelston IP

Pub. Number AU-A-2012216488

Parent 2009262199

Filing date 28 August 2012

Wipo publication date 13 September 2012

International Classifications

C07K 16/22 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

13 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216488

13 September 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216489-Social based automatic trading of currencies, commodities, securities and other financial instruments

2012216487-Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides